HCR and Global IQ Inc. announce Teaming Partner Agreement

Harrison Clinical Research of Munich, Germany and Global IQ Inc., of Edmonton, Alberta, Canada, announced today that they have completed a teaming agreement, providing the operational infrastructure to ensure the seamless conduct of clinical studies by the two organizations in their respective regions.  The teaming agreement provides for bridging SOPs, common training procedures and a single point of client contact for clinical studies carried out jointly by the companies. 

Although there is no ownership interest of Global IQ by Harrison Clinical Research, the parties continue to collaborate on several studies with common clients under the auspices of the teaming arrangement.

HCR is an international contract research organization offering full service clinical research capabilities to the pharmaceutical industry. With Phase I (clinical pharmacology unit in Munich, Germany) to Phase IV capabilities, HCR focuses on providing the services our clients require for the successful clinical development and registration of new pharmaceutical, biological and nutraceuticals products as well as medical devices by delivering the highest quality data, achieving promised enrolment and meeting project timelines.

Global IQ Inc. has offices in Canada, Mexico and Argentina and collaborates with other CROs to provide clinical study services in these countries to assist with more rapid recruitment and completion of international clinical studies with high quality data.